Letters
Imaging peripheral disease
Gadolinium contrast may be risky in kidney disease
BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39254.924641.1F (Published 28 June 2007) Cite this as: BMJ 2007;334:1335- Peter C Thomson, research fellow in nephrology1,
- Tara A Collidge, specialist registrar1,
- Patrick B Mark, specialist registrar2,
- Jamie P Traynor, specialist registrar2
- 1Renal Unit, Glasgow Royal Infirmary, Glasgow G4 0SF
- 2Renal Unit, Western Infirmary, Glasgow G11 6PE
- peter.thomson{at}northglasgow.scot.nhs.uk
Collins et al and the accompanying editorial conclude that contrast enhanced magnetic resonance angiography (MRA) is a viable alternative to conventional contrast angiography for assessing patients with peripheral arterial disease before treatment.1 2 The authors found an adverse event rate of up to 10% associated with contrast …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.